Results 31 to 40 of about 2,547,606 (153)
Due to loss of p16ink4a in pancreatic ductal adenocarcinoma (PDA), pharmacological suppression of CDK4/6 could represent a potent target for treatment. In PDA models CDK4/6 inhibition had variable effect on cell cycle, but yielded accumulation of ATP and
J. Franco +4 more
semanticscholar +1 more source
Purpose: Increased β-adrenergic receptor (β-AR) signaling has been shown to promote the creation of an immunosuppressive tumor microenvironment (TME). Preclinical studies have shown that abrogation of this signaling pathway, particularly β2-AR, provides ...
S. Gandhi +18 more
semanticscholar +1 more source
Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer
SUMMARY Approximately 30% of triple-negative breast cancers (TNBCs) exhibit functional loss of the RB tumor suppressor, suggesting a target for precision intervention.
A. Witkiewicz +6 more
semanticscholar +1 more source
UEG Week 2023 Poster Presentations
United European Gastroenterology Journal, Volume 11, Issue S8, Page 535-1498, October 2023.
wiley +1 more source
Objective Pancreatic ductal adenocarcinoma (PDAC) is a therapy recalcitrant disease with the worst survival rate of common solid tumours. Preclinical models that accurately reflect the genetic and biological diversity of PDAC will be important for ...
E. Knudsen +7 more
semanticscholar +1 more source
Pancreatic ductal adenocarcinoma (PDAC) harbors the worst prognosis of any common solid tumor, and multiple failed clinical trials indicate therapeutic recalcitrance.
A. Witkiewicz +7 more
semanticscholar +1 more source
UEG Week 2022 Poster Presentations
United European Gastroenterology Journal, Volume 10, Issue S8, Page 473-1092, October 2022.
wiley +1 more source
Acquired resistance to CDK4/6 small molecule inhibitors in breast cancer arises through mechanisms that are yet uncharacterized. In this study, we used a kinome-wide siRNA screen to identify kinases which when downregulated yields sensitivity to the CDK4/
V. Jansen +18 more
semanticscholar +1 more source
Acetylcholinesterase: Structure, dynamics, and interactions with organophosphorus compounds
Abstract Acetylcholinesterase (AChE) is an enzyme that hydrolyzes the neurotransmitter acetylcholine (ACh), removing it from the synaptic cleft after the transmission of an electrical signal, making it an essential component of chemical neurotransmission. AChE is a serine hydrolase, containing a catalytic triad of Ser/His/Glu.
Li‐Wei Hung +3 more
wiley +1 more source
Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ
We have recently proposed a new mechanism for explaining energy transfer in cancer metabolism. In this scenario, cancer cells behave as metabolic parasites, by extracting nutrients from normal host cells, such as fibroblasts, via the secretion of ...
D. Whitaker-Menezes +13 more
semanticscholar +1 more source

